Compass Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.57M Buy
52,783
+5,118
+11% +$490K 1.13% 38
2025
Q4
$4.58M Buy
47,665
+2,186
+5% +$212K 1.14% 36
2025
Q3
$4.33M Buy
45,479
+1,328
+3% +$122K 0.97% 41
2025
Q2
$3.85M Sell
44,151
-3,870
-8% -$328K 0.92% 40
2025
Q1
$4.32M Sell
48,021
-1,652
-3% -$148K 1.1% 34
2024
Q4
$3.97M Sell
49,673
-370
-0.7% -$32K 0.96% 37
2024
Q3
$4.51M Sell
50,043
-14,226
-22% -$1.2M 1.06% 35
2024
Q2
$5.06M Sell
64,269
-71
-0.1% -$5.82K 1.25% 26
2024
Q1
$5.61M Buy
64,340
+6,181
+11% +$528K 1.4% 18
2023
Q4
$4.79M Buy
58,159
+4,158
+8% +$317K 1.34% 20
2023
Q3
$4.23M Buy
54,001
+2,397
+5% +$201K 1.33% 22
2023
Q2
$4.55M Buy
51,604
+1,611
+3% +$139K 1.37% 19
2023
Q1
$4.03M Buy
49,993
+10,073
+25% +$821K 1.28% 26
2022
Q4
$3.1M Buy
+39,920
New +$3.24M 1.02% 35

Other funds holding MDT

Compass Wealth Management's MDT Position: Q1 2026 in Review

Compass Wealth Management increased its Medtronic (MDT) stake by 11% in Q1 2026, buying an estimated $490K and bringing the position to 52,783 shares worth $4.57M. The position accounts for 1.13% of the portfolio, ranked #38.

Compass Wealth Management first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.61M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Compass Wealth Management held 52,783 shares of Medtronic worth $4.57M as of Q1 2026.
  • Compass Wealth Management bought 5,118 Medtronic shares in Q1 2026, an estimated $490K.
  • Medtronic made up 1.13% of Compass Wealth Management's portfolio in Q1 2026, its #38 holding.
  • Compass Wealth Management first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Compass Wealth Management's Medtronic position peaked at $5.61M in Q1 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Compass Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.